TapewireFind a company

person · Reporting owner

Schlanger David J

Disclosed activity across 1 company

Tapewire entity
70264
SEC CIK
0001576145

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Progyny, Inc.PGNY · Entity 4521Director · Executive ChairmanJanuary 02, 2026January 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Progyny, Inc.

Report date January 02, 2026 · Filed January 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect238,462 Reported balance After 2026-01-02 transaction · row 1
1 source row

Row 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462

F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 104 $27.24 $2,832.96
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

Read SEC document
August 04, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 104 $0.91 $94.64
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · derivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,834,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $27.24 $544,800.00
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.14 to $27.36 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
August 03, 2020 Filed Aug 6, 2020 00:53 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-045391 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 20:41 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-042274 · doc4.xml · derivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,854,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 20:41 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $25.94 $518,800.00
Disclosure

SEC source: 0001209191-20-042274 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.82 to $26.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2020 Filed Jul 13, 2020 20:41 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-042274 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 08, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · derivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,874,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 08, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $25.97 $519,400.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.76 to $26.29 inclusive.

Read SEC document
July 08, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · derivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,894,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $25.85 $517,000.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.73 to $26.56 inclusive.

Read SEC document
July 07, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · derivative · entry 7

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,914,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 06, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $26.62 $532,400.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.16 to $26.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
July 06, 2020 Filed Jul 8, 2020 21:43 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-041796 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · derivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,934,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $26.02 $520,400.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $26.54 inclusive.

Read SEC document
July 02, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · derivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,954,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
July 01, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $25.95 $519,000.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.66 to $26.27 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
July 01, 2020 Filed Jul 6, 2020 22:17 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-041139 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · derivative · entry 10

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,974,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $25.07 $501,400.00
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25 inclusive.

Read SEC document
June 08, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 58,075 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · derivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,994,384

Underlying: Common Stock · 58,075 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 58,075 $24.93 $1,447,809.75
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.88 to $25.03 inclusive.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 58,075 $0.91 $52,848.25
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 638,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 04, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 11,784 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · derivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,052,459

Underlying: Common Stock · 11,784 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 04, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 11,784 $24.94 $293,892.96
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.84 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
June 04, 2020 Filed Jun 9, 2020 01:12 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 11,784 $0.91 $10,723.44
Disclosure

SEC source: 0001209191-20-035180 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 6,741 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · derivative · entry 10

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,064,243

Underlying: Common Stock · 6,741 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 6,741 $24.74 $166,772.34
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.79 inclusive.

Read SEC document
June 03, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 6,741 $0.91 $6,134.31
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 5

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 586,751

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,400 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · derivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,070,984

Underlying: Common Stock · 3,400 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 3,400 $24.70 $83,980.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 4

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.65 to $24.79 inclusive.

Read SEC document
June 02, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 3,400 $0.91 $3,094.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 3

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 583,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · derivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,074,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
June 01, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 20,000 $24.82 $496,400.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 2

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.62 to $25.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).

Read SEC document
June 01, 2020 Filed Jun 4, 2020 00:30 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-034322 · doc4.xml · nonDerivative · entry 1

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · derivative · entry 16

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,094,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
May 15, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 2,807 $25.65 $71,999.55
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 12

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.55 to $25.75 inclusive.

Read SEC document
May 15, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 8,489 $25.21 $214,007.69
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 11

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 582,817

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.55 to $25.54 inclusive.

Read SEC document
May 15, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 8,704 $24.14 $210,114.56
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 10

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,306

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.49 inclusive.

Read SEC document
May 15, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 9

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20,000 $0.00 Strike: $0.91 $0.00
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · derivative · entry 15

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,114,384

Underlying: Common Stock · 20,000 shares

Expires 2027-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on January 16, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Read SEC document
May 14, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 2,993 $25.05 $74,974.65
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 8

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 580,010

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.94 to $25.55 inclusive.

Read SEC document
May 14, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 17,007 $24.51 $416,841.57
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 7

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 583,003

F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 12, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.94 to $24.91 inclusive.

Read SEC document
May 14, 2020 Filed May 15, 2020 23:35 UTC Progyny, Inc. PGNY · Entity 4521 Exercise / conversionCommon Stock 20,000 $0.91 $18,200.00
Disclosure

SEC source: 0001209191-20-029868 · doc4.xml · nonDerivative · entry 6

Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600,010

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.